Stocks to keep an eye on May 28, 2015

( click to enlarge )
FibroGen Inc (NASDAQ:FGEN) broke out of the bottom base formation accompanied by strong volume. This could be the start of a nice bounce and the extreme oversold conditions will also help. As i said on twitter, i went long. Watch for a continuation move tomorrow. If it breaks above 19.19 (9EMA), it could reach an initial target of 20.04 and then a secondary target at 21

( click to enlarge )
Himax Technologies, Inc. (NASDAQ:HIMX) finished near its highs and has closed again above the 50-day exponential moving average. So, tomorrow keep an eye on the stock for a possible breakout over $6.70 on a close basis.

( click to enlarge )
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) On radar. I like over 40.99 for a trade. 13EMA is support.

( click to enlarge )
Agenus Inc (NASDAQ:AGEN) Strong move today on solid volume. Traders should watch for a potential breakout over 8. The MACD is positive and above its rising signal line. A breakout above the key resistance could take the stock much higher as the daily chart shows little resistance.

( click to enlarge )
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Basing here. Over $9.25 would be buy trigger. As long as the stock holds above the 50-day EMA support line the short-term picture should remain positive.


Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.